NickPowellLab retweeted
We're #hiring new non‑clinical Assistant Professors at @ImperialMed!
Want to join us at @ImperialImmuno?
Make sure to choose ‘Immunology and Inflammation’ as your first preference when applying.
✍️Apply by 11 March 2026.
imperial.ac.uk/jobs/search-jo…
Want to join us at @ImperialImmuno?
Make sure to choose ‘Immunology and Inflammation’ as your first preference when applying.
✍️Apply by 11 March 2026.
imperial.ac.uk/jobs/search-jo…
0
2
5
641
NickPowellLab retweeted
A true legend in the field of IBD - your memory will continue to inspire us
Fitting tribute to Prof. Brian Feagan from #ECCO Family
ecco-ibd.eu/publications/i…
Fitting tribute to Prof. Brian Feagan from #ECCO Family
ecco-ibd.eu/publications/i…
1
12
42
3,334
NickPowellLab retweeted
Great progress in recruitment to @ACESO_ASUC this week with 7 patients randomised 📈
2 patients each included by @IbdHull & @imperialcollege teams
1 patient each included by teams from Manchester , Oxford , Leeds
Thank you to participants and 🙏🏼🙏🏼to site teams for all the hard work🇧- to make progress in a challenging phenotype of #IBD
#Collaboration
2 patients each included by @IbdHull & @imperialcollege teams
1 patient each included by teams from Manchester , Oxford , Leeds
Thank you to participants and 🙏🏼🙏🏼to site teams for all the hard work🇧- to make progress in a challenging phenotype of #IBD
#Collaboration
0
3
11
982
NickPowellLab retweeted
MDR researchers launch a new trial, funded by @GSK, exploring improved vaccine responses in patients with inflammatory bowel disease #IBD (@NickPowellLab @IHepatology)
Find out more ⬇️
imperial.ac.uk/news/271355/ne…
Find out more ⬇️
imperial.ac.uk/news/271355/ne…
0
1
5
193
NickPowellLab retweeted
Congratulations to @imperialcollege team led by Dr James Alexander & @NickPowellLab for randomising their first patient to @ACESO_ASUC study
And they have done that within 2️⃣4️⃣hours of receiving green light !!!
🚦👏👏
Thanks to the participant and the entire team in partsabel
Many more to come 🤞
And they have done that within 2️⃣4️⃣hours of receiving green light !!!
🚦👏👏
Thanks to the participant and the entire team in partsabel
Many more to come 🤞
0
1
9
481
NickPowellLab retweeted
Our eagerly awaited #RCT on #JAKis #Upadacitinib in Acute Severe Colitis is now recruiting
The ACESO study @ACESO_ASUC
❇️Double blind placebo controlled
❇️ Upfront #upa + IV steroids Vs Iv steroids + Placebo
❇️Option for entry into rescue sub-studies for non responders ay hello 👋 for updates if at #BSGLIVE25
The ACESO study @ACESO_ASUC
❇️Double blind placebo controlled
❇️ Upfront #upa + IV steroids Vs Iv steroids + Placebo
❇️Option for entry into rescue sub-studies for non responders ay hello 👋 for updates if at #BSGLIVE25
3
24
59
3,958
NickPowellLab retweeted
Congratulations to Professor Ailsa Hart, IBD Research Lead at St Mark’s. 🌟
At ECCO 2025, Professor Hart presented the latest results of SC guselkumab for moderate to severe active Crohn’s disease at the prestigious Saturday plenary session. Following this, she was awarded the half of a global team of researchers to advance perianal Crohn’s disease research worldwide — a remarkable achievement driving innovation in IBD care.
A fantastic recognition of her dedication to improving patient outcomes! 🙌🏻
At ECCO 2025, Professor Hart presented the latest results of SC guselkumab for moderate to severe active Crohn’s disease at the prestigious Saturday plenary session. Following this, she was awarded the half of a global team of researchers to advance perianal Crohn’s disease research worldwide — a remarkable achievement driving innovation in IBD care.
A fantastic recognition of her dedication to improving patient outcomes! 🙌🏻
2
11
83
4,107
NickPowellLab retweeted
Albeit retrospective, an important reassuring data on safety of GLP1s weight reduction in IBD.
I tell my pts that Obesity+associated HTN/diabetes/hyperlipedmia end up killing far more IBD pts than (fortunately very very rare now) death d/t IBD itself.
This is whats at stake !
I tell my pts that Obesity+associated HTN/diabetes/hyperlipedmia end up killing far more IBD pts than (fortunately very very rare now) death d/t IBD itself.
This is whats at stake !
Safety and Effectiveness of Glucagon-like Peptide-1 receptor agonists in #IBD: our experience @WashUMedIBD @WashUMedGastro led @MalekAyoubMD @SRAnderson121 #SarahCoats @AmJGastro journals.lww.com/ajg/abstract/9…
0
3
17
1,788
NickPowellLab retweeted
CTLA-4 expressing ILCs modulate mucosal homeostasis in a microbiota dependent manner @NickPowellLab @DrJonLo @Lukuscyte
nature.com/articles/s4146…
nature.com/articles/s4146…
1
6
44
4,167
Thank you for these kind words Steven. Wonderful to be here!
🇦🇺 🤝 🇬🇧
🇦🇺 🤝 🇬🇧
I normally switch off when I see a basic science slide but @NickPowellLab now got me fascinated by IL22! I wish all translational researchers could present concepts so clearly for simple clinical people like me 🤯
@AGWmeeting #AGW2024 #AGW24
1
0
12
941
Thank you Kate!
And thank you for putting together a wonderful tour of the wineries of the Adelaide Hills! Beautiful country and wonderful wine!
🍇 🍷 😊 👏
And thank you for putting together a wonderful tour of the wineries of the Adelaide Hills! Beautiful country and wonderful wine!
🍇 🍷 😊 👏
Masterful Bushell Lecture by @NickPowellLab on his IBD mucosal immunology research - specifically,
looking at IL-22 and its role in IBD - predicts response to ustekinumab, unregulates neutrophil attracting chemokines, among others. #AGW2024
0
0
16
943
Excited to attend my first Australian Gastroenterology Week in Adelaide. Thank you to my wonderful Australian colleagues for their generous hospitality @Prof_NickTalley @DocKateLynch Jane Andrews Susan Connor
3
3
30
3,579
NickPowellLab retweeted
Moving towards gut dysbiosis testing in cancer immunotherapy resistance.
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome: Cell cell.com/cell/fulltext/…
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome: Cell cell.com/cell/fulltext/…
1
7
13
1,229
NickPowellLab retweeted
🏆🌍 @imperialcollege ranked #2 in the world and 1st in the UK and Europe in this 2025 QS @worlduniranking - hubs.ly/Q02BdCrr0
We're delighted that the ranking reflects how we've consistently improved innovation support and entrepreneurship for real-world impact.💙
We're delighted that the ranking reflects how we've consistently improved innovation support and entrepreneurship for real-world impact.💙
0
2
4
511
NickPowellLab retweeted
On #WorldIBDDay, Open Targets project lead @anderson_carl introduces our most ambitious project yet: @OpenIBD!
Today is #WorldIBDDay 🌎
Check out our video with @anderson_carl to discover more about what IBD is and how @OpenIBD aims to find new ways to predict, monitor, and treat it.🔎
@OpenTargets @DrChrisLamb @UniofNewcastle @NewcastleHosps #IBDMythBusting
sanger.ac.uk/news_item/ambi…
1
11
28
12,527
NickPowellLab retweeted
Congratulations to all #OurImperial graduates who celebrated their achievements this week @RoyalAlbertHall.🎓
Congratulations also to our award-winners: Dr @LindsayDewa, Prof @p_openshaw, @AglaiaFreccero and Dr @teeoyebamiji!🎉
More 👇
imperial.ac.uk/news/253214/ro…
Congratulations also to our award-winners: Dr @LindsayDewa, Prof @p_openshaw, @AglaiaFreccero and Dr @teeoyebamiji!🎉
More 👇
imperial.ac.uk/news/253214/ro…
0
6
20
5,370
NickPowellLab retweeted
It’s actually still going! Our ceremony starts at 8.15 this evening and you can join us online imperial.ac.uk/students/gradu… #OurImperial
Graduation Day 2024 = done ✔️
We hope all your dreams turn into reality as you move on to the next chapter in your life. Whether you are staying with us or departing for new adventures, you will always be part of #OurImperial.
Congratulations to you all! 🥳
0
2
8
1,851
NickPowellLab retweeted
Every important IMIBD session @DDWMeeting in one digestible table.
👇🏼👇🏼👇🏼
👇🏼👇🏼👇🏼
Getting ready for @DDWMeeting?
Here is our annual sneak peek at our IMIBD programming to help you prepare!
We have focused more than ever on investigator-initiated research as well as novel clinical and basic talks and symposia including:
- 5 state-of-the art basic, ical symposia
- 2nd annual IBD late breakers and innovations in IBD research session
- Several dedicated basic and clinical research sessions on Diet, Environment, as well as Pain, Sleep, and Fatigue in IBD
- IBD Distinguished Abstract Plenary Session
- 8 basic/ translational research abstract sessions
- 12 clinical research abstract sessions
- 650+ posters, with poster tours led by expert guides, available.
On behalf of myself and vice chair @AshwinMDIBD as well as our colleagues who spent so many hours, including abstract reviewers, abstract chairs and vice chairs, IMIBD councilors, speakers, research presenters, and dedicated @AmerGastroAssn staff who make it look easy, I hope you enjoy our IBD programming at this year’s DDW.
See you in Washington DC!
1
4
27
3,617
Don’t forget to submit your applications for ECCO Fellowships and Grants (submission deadline May 2)!
ecco-ibd.eu/science/fellow…
ecco-ibd.eu/science/ecco-y…
ecco-ibd.eu/science/fellow…
ecco-ibd.eu/science/ecco-y…
0
0
1
384